Arch Dis Child. Published Online First: 13 October 2005. doi:10.1136/adc.2005.081224
Original articles |
Post-phototherapy neonatal bilirubin rebound: A potential cause of significant hyperbilirubinaemia
1 Shaare Zedek Medical Center, Israel
2 Be'er Sheva, Israel
* To whom correspondence should be addressed. E-mail: kaplan{at}cc.huji.ac.il.
Accepted 19 September 2005
Abstract
Objective:To determine the incidence of post- phototherapy neonatal plasma total bilirubin (PTB) rebound.
Methods:A prospective clinical survey was performed on 226 term and near-term neonates treated with phototherapy in the well baby nursery of the Shaare Zedek Medical Center from January 2001 to September 2002. Neonates were tested for PTB 24 ± 12 hr after discontinuation of phototherapy, with additional testing as clinically indicated. The main outcome measure, significant bilirubin rebound, was defined as a post-phototherapy PTB > 256 µmol/L. Phototherapy was not reinstituted in all cases of rebound, but rather according to clinical indications.
Results:30 (13.3%) neonates developed significant rebound (mean (SD) PTB 287 ± 27 µmol/L, upper range 351 µmol/L). 22 of these (73%) were retreated with phototherapy at mean PTB 296 ± 29 µmol/L. Multiple logistic regression analysis demonstrated significant risk for aetiologic risk factors including positive direct Coombs' test (Odds Ratio 2.44, 95% Confidence Interval 1.25-4.74, p=0.028) and gestational age <37 weeks (Odds ratio 3.21, 95% Confidence Interval 1.29-7.96, p=0.036). A greater number of neonates rebounded among those in whom phototherapy was commenced < 72 hours (26/152, 17%) compared with > 72 hours (4/74, 5.4%), Odds Ratio 3.61, 95% Confidence Interval 1.21 - 10.77.
Conclusion:Post-phototherapy neonatal bilirubin rebound to clinically significant levels may occur, especially in cases of prematurity, direct Coombs' test positivity, and those treated < 72 hours. These risk factors should be taken into account when planning post- phototherapy follow up.
Keywords: bilirubin, coombs' positivity, phototherapy, prematurity, rebound
This article has been cited by other articles:
-
Maisels, M. J., McDonagh, A. F.
(2008). Phototherapy for Neonatal Jaundice. NEJM
358: 920-928
[Full Text] -
Djokomuljanto, S, Quah, B S, Surini, Y, Noraida, R, Ismail, N Z N, Hansen, T W R, Van Rostenberghe, H
(2006). Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. Arch. Dis. Child. Fetal Neonatal Ed.
91: F439-F442
[Abstract] [Full Text] -
Erdeve, O, Kaplan, M, Hammerman, C
(2006). Rebound bilirubin: on what should the decision to recommence phototherapy be based? * Authors' reply. Arch. Dis. Child.
91: 623-623
[Full Text] -
(2006). Risk Factors for Rebound Hyperbilirubinemia. JWatch Pediatrics
2006: 2-2
[Full Text]
eLetters:
Read all eLetters
- Rebound bilirubin: what is the keypoint to recommence phototherapy?
- Omer Erdeve
- ADC Online, 14 Mar 2006 [Full text]
- Author's Response: Post-phototherapy bilirubin rebound
- Michael Kaplan, et al.
- ADC Online, 15 Mar 2006 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



